Biogen Inc. (NASDAQ:BIIB)’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases has fueled a 6% rise in its share price over the past ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other most ...

Biogen Inc. (NASDAQ: BIIB) TD Cowen 45th Annual Health Care Conference March 3, 2025 9:10 AM ET Company Participants Chris Viehbacher - CEO Conference Call Participants Phil Nadeau - TD Cowen Phil ...

Biogen Inc. (NASDAQ: BIIB) Q4 2023 Earnings Conference Call February 13, 2024 8:00 AM ET Company Participants Chuck Triano - Head of Investor Relations Chris Viehbacher - President and Chief ...

BIIB stands above RGEN thanks to its solid earnings outlook, and based on these valuation figures, we also feel that BIIB is the superior value option right now.

BIIB sticks out from RGEN in both our Zacks Rank and Style Scores models, so value investors will likely feel that BIIB is the better option right now. Infrastructure Stock Boom to Sweep America ...

Is BIIB stock a buy or sell? Biogen Inc. (NASDAQ: BIIB) investors should pay attention to an increase in enthusiasm from smart money of late. Biogen Inc. (NASDAQ: BIIB) was in 63 hedge funds ...